LAVAL, QC / ACCESSWIRE / April 4, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced the results from the third edition of its patient perspectives survey, an annual survey of U.S. adults living with irritable bowel syndrome (IBS) or chronic idiopathic constipation (CIC). The report, Patient Perspectives: Impacts of Living with IBS, offers a current understanding of the behaviors and experiences of the IBS and CIC patient population, including insights on diagnosis, barriers to provider discussions, and symptom management. The report, which was developed based on a nationwide survey conducted in partnership…
Author: Praveen Suthrum
CARLSBAD, Calif., April 6, 2023 (Newswire.com) – Virgo Surgical Video Solutions, Inc. (“Virgo”) and The Clinical Trials Network (“CTNx”) today announced a strategic partnership to expand and accelerate the identification, selection, and enrollment of patients in GI clinical trials across CTNx’s expansive network of 30+ high-quality GI trial sites using Virgo’s endoscopy data capture and artificial intelligence platform. The Clinical Trials Network brings physicians together to create a leading source of high-quality research sites to present to trial sponsors. Virgo’s cloud-based, HIPAA- and SOC-2-compliant platform allows gastroenterologists to automatically record, store, and manage endoscopy videos without interrupting clinical workflows. Artificial…
PORTSMOUTH, N.H., April 3, 2023 /PRNewswire/ — Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), announced the launch of the alpHaONE system that is specifically designed to diagnose gastroesophageal reflux disease (GERD) and offers up to 96 hours of monitoring data. GERD is a chronic medical condition caused by the flow of contents from the stomach upwards into the esophagus resulting in both symptoms and complications. It is estimated that 20% of the US population suffers from GERD with the most common symptoms being heartburn and regurgitation. Read More
In this podcast episode, Douglas Drossman, MD, and Johannah Ruddy MEd, discuss methods of destigmatizing chronic illness for patients and physicians, technology’s effect on the doctor-patient relationship and more. Read More
US regulators may soon clear blood-based biomarker tests for colorectal cancer (CRC), expanding potential options for patients seeking more convenient forms of screening. Most recently, Guardant Health, Inc, announced the completion of its US premarket approval application for its Shield blood test to screen for CRC. Approval by the US Food and Drug Administration (FDA) would position Guardant to later secure Medicare coverage for its test. Rival companies, including CellMax Life, Freenome, and Exact Sciences, which already offers the stool-based Cologuard product, are pursuing similar paths in their development of blood tests for CRC. Read More
United Digestive recently partnered with private equity firm Kohlberg & Company, ending its partnership with Frazier Healthcare Partners, who created the platform in tandem with Atlanta Gastroenterology Associates in 2018. United Digestive CEO Mark Gilreath and President Neal Patel, MD, spoke with Becker’s to discuss why the company decided to choose a new private equity partner and what is next for the management services organization. Question: What made you decide to find a new private equity partner? Mark Gilreath: Private equity firms generally hold those portfolio companies for about five to seven years. I think that’s average. When the company…
A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge, lifestyle and treatments for these conditions. The findings, published in the peer-reviewed journal Clinical and Molecular Hepatology, highlights the AI system’s potential to play a role in clinical practice. “Patients with cirrhosis and/or liver cancer and their caregivers often have unmet needs and insufficient knowledge about managing and preventing complications of their disease,” said Brennan Spiegel, MD, MSHS, director of Health Services Research at Cedars-Sinai and co-corresponding…
This article was originally posted in GI & Hepatology News. In this issue of Perspectives, Dr. RJ Sealock, assistant professor of medicine at the Baylor College of Medicine, and Dr. Thiru Muniraj, associate professor of medicine at the Yale School of Medicine, share their experiences performing minimally invasive alternatives to surgery, discussing both sides of gastrointestinal perforations – treating and creating. Dr. Sealock discusses how endoscopic vacuum therapy (EVT) overcomes many of the limitations of traditional endoscopic closure or diversion using covered stents and can be considered as a first-line approach for a majority of indications. He describes how we…
United Digestive gets a “second bite” | Dr. Weber on GI’s workforce shortage Key Recommendations from AGA Conference on the Future of AI in GI (GI & Endoscopy News)The conference reflected the increasing role that AI has started to play in GI and hepatology and the increasing recognition that leaders in the field will need to collectively address. United Digestive Partners with Kohlberg & Company (PR Newswire)NY-based Kohlberg & Company announced that it has partnered with United Digestive. * Praveen predicted these “second bites” in March 2019. Read Page 32 from Private Equity in Gastroenterology and in Scope Forward. Should…
Last fall, the American Gastroenterological Association convened a multidisciplinary conference in Bethesda, Md., titled “The Future of AI in Gastroenterology.” The conference reflected the increasing role that artificial intelligence has started to play in gastroenterology and hepatology, and the increasing recognition that leaders in the field will need to collectively address systemic barriers and biases and provide broad education to the GI community to foster responsible AI adoption. Below are a few key takeaways from the conference. Most of the sessions covered during the conference, and most of the literature on AI in GI, are related to endoscopy and computer…